Burden and trends of breast cancer worldwide: Opportunities for prevention?
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of July 1 - July 10, 2021.
Alerts this week covers the US FDA approval for enfortumab vedotin for pretreated metastatic or advanced bladder cancer. Dr Morgan also discusses papers from Lancet Oncology, Journal of Clinical Oncology and IASLC.
In the end,
Dr Morgan mentions the OncoAlert Colloquim which is coming in December this year.
You can watch Dr Morgan's previous roundup here.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Laser oncosurgery - A new perspective in treating cancer
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
ESMO 2023: Highlights and analysis
Hodgkin’s and non-Hodgkin’s lymphomas (NHL)